|
|
| Zeile 1: |
Zeile 1: |
| | __NOTOC__ | | __NOTOC__ |
| | *'''[[Further reading]]''' | | *'''[[Further reading]]''' |
| − | {{tp|p=32362782|t=2020. Aktuelle Informationen zu COVID-19 auf einer Plattform ? zeitschriftenübergreifend |pdf=|usr=}}
| |
| − | *[https://www.gisaid.org/ GISAID database on covid19]
| |
| | | | |
| | *'''[[Unproven ideas]]''' | | *'''[[Unproven ideas]]''' |
| | *'''[[Reviews on covid19 disease]]''' | | *'''[[Reviews on covid19 disease]]''' |
| − | {{tp|p=32330209|t=ä. A precision medicine approach to managing 2019 novel coronavirus pneumonia |pdf=|usr=}}
| |
| − | {{tp|p=32278960|t=2020. COVID-19 from veterinary medicine and one health perspectives: What animal coronaviruses have taught us |pdf=|usr=}}
| |
| − | {{tp|p=32345483|t=ä. CCOVID-19 with Pulmonary Involvement. An Autoimmune Disease of Known Cause |pdf=|usr=}}
| |
| − | {{tp|p=32334862|t=ä. COVID-19�: caract�ristiques cliniques, biologiques et radiologiques chez l?adulte, la femme enceinte et l?enfant Une mise au point au c?ur de la pand�mie |pdf=|usr=}}
| |
| − | {{tp|p=32336927|t=ä. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Emergence, History, Basic and Clinical Aspects |pdf=|usr=}}
| |
| − | {{tp|p=32371230|t=2020. Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: A global health emergency |pdf=|usr=}}
| |
| − | {{tp|p=32344226|t=2020. COVID-19: Disease, management, treatment, and social impact |pdf=|usr=}}
| |
| − | {{tp|p=32321874|t=2020. The Coronavirus Disease 2019 (COVID-19) Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32179124|t=2020. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis |pdf=|usr=}}
| |
| − | {{tp|p=32359479|t=2020. COVID-19: Epidemiology, Evolution, and Cross-Disciplinary Perspectives |pdf=|usr=}}
| |
| − | {{tp|p=32304191|t=2020. Novel coronavirus disease (COVID-19) in children |pdf=|usr=}}
| |
| − | {{tp|p=32293832|t=2020. Coronaviruses and SARS-COV-2 |pdf=|usr=}}
| |
| − | {{tp|p=32366061|t=2020. The COVID-19 Pandemic: Clinical Information for Ophthalmologists |pdf=|usr=}}
| |
| − | {{ttp|p=32250347|t=2020. 48pp, Consensus Report from Turkish Society of Cardiology: COVID-19 and Cardiovascular Diseases. What cardiologists should know. (25th March 2020)|pdf=https://www.journalagent.com/z4/download_fulltext.asp?pdir=tkd&ppdf=2&plng=eng&un=TKDA-97198|usr=}}
| |
| − | {{tp|p=32290077|t=2020. Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2 |pdf=|usr=}}
| |
| − | {{tp|p=32327904|t=2020. SARS-COV-2 infection (coronavirus disease 2019) for the gastrointestinal consultant |pdf=|usr=}}
| |
| − | {{tp|p=32193831|t=ä. Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center?s observational study |pdf=|usr=}}
| |
| − | {{tp|p=32313806|t=ä. 2019 Novel coronavirus (COVID-19) overview |pdf=|usr=}}
| |
| − | {{tp|p=32230900|t=2020. Virology, Epidemiology, Pathogenesis, and Control of COVID-19 |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Clinical guidelines and advice]]''' | | *'''[[Clinical guidelines and advice]]''' |
| − | {{tp|p=32327870|t=ä. Recomendaciones sobre el tratamiento antitromb�tico durante la pandemia COVID-19 Posicionamiento del Grupo de Trabajo de Trombosis Cardiovascular de la Sociedad Espa�ola de Cardiolog�a |pdf=|usr=}}
| |
| − | {{tp|p=32277760|t=2020. Thromboprophylaxis and laboratory monitoring for in-hospital patients with COVID-19 - a Swiss consensus statement by the Working Party Hemostasis |pdf=|usr=}}
| |
| − | {{tp|p=32134111|t=2020. Understanding COVID-19 new diagnostic guidelines - a message of reassurance from an internal medicine doctor in Shanghai |pdf=|usr=}}
| |
| − | {{tp|p=32034659|t=ä. Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts? consensus statement |pdf=|usr=}}
| |
| − | {{tp|p=32026148|t=ä. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus |pdf=|usr=}}
| |
| − | {{tp|p=32333248|t=ä. Updated diagnosis, treatment and prevention of COVID-19 in children: experts? consensus statement (condensed version of the second edition) |pdf=|usr=}}
| |
| | | | |
| | | | |
| | *'''[[Respiration mgmt]]''' | | *'''[[Respiration mgmt]]''' |
| − | {{tp|p=32204751|t=2020. Consideration of the respiratory support strategy of severe acute respiratory failure caused by SARS-CoV-2 infection in children |pdf=|usr=}}
| |
| | | | |
| | *'''[[Diagnosis (Laboratory)]]''' | | *'''[[Diagnosis (Laboratory)]]''' |
| − | {{tp|p=C7187661|t=ä. Group Testing for SARS-CoV-2: Forward to the Past?|pdf=|usr=}}
| |
| − | {{tp|p=32329979|t=2020. COVID-19 rapid antibody cassette point of care tests: practical considerations |pdf=|usr=}}
| |
| − | {{ttp|p=32358057|t=2020. Overcoming the bottleneck to widespread testing: A rapid review of nucleic acid testing approaches for COVID-19 detection |pdf=|usr=}}
| |
| − | {{ttp|p=32373393|t=ä. Rapid and Sensitive Detection of COVID-19 Using CRISPR/Cas12a-based Detection with Naked Eye Readout, CRISPR/Cas12a-NER |pdf=|usr=}}
| |
| − | {{tp|p=32270436|t=ä. Detection of serum IgM and IgG for COVID-19 diagnosis |pdf=|usr=}}
| |
| − | {{tp|p=32327566|t=2020. One ventilator for two patients: feasibility and considerations of a last resort solution in case of equipment shortage |pdf=|usr=}}
| |
| − | {{tp|p=32378843|t=2020. Akutt lungesviktsyndrom hos covid-19-pasient med negative nasofarynksprover |pdf=|usr=}}
| |
| − | {{tp|p=32311437|t=ä. Detection and analysis of nucleic acid in various biological samples of COVID-19 patients |pdf=|usr=}}
| |
| − | {{tp|p=32283215|t=ä. False negative rate of COVID-19 is eliminated by using nasal swab test |pdf=|usr=}}
| |
| − | {{tp|p=32239445|t=ä. Development of a Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2 |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Diagnosis (Lung CT, Sonography)]]''' | | *'''[[Diagnosis (Lung CT, Sonography)]]''' |
| − | {{tp|p=32321099|t=ä. COVID-19 - Computed tomography findings in two patients in Petr�polis, Rio de Janeiro, Brazil |pdf=|usr=}}
| |
| − | {{tp|p=32267461|t=ä. Chest radiography and computed tomography findings from a Brazilian patient with COVID-19 pneumonia |pdf=|usr=}}
| |
| − | {{tp|p=32215898|t=2020. CT-Morphologie von COVID-19: Fallbeispiel und Literaturubersicht |pdf=|usr=}}
| |
| − | {{tp|p=32193883|t=2020. CT appearance of severe, laboratory-proven coronavirus disease 2019 (COVID-19) in a Caucasian patient in Berlin, Germany |pdf=|usr=}}
| |
| − | {{tp|p=32241067|t=2020. Clinics in Diagnostic Imaging: COVID-19 atypical pneumonia |pdf=|usr=}}
| |
| − | {{tp|p=32312025|t=2020. Variable computed tomography appearances of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32373237|t=2020. Multicenter cohort study demonstrates more consolidation in upper lungs on initial CT increases the risk of adverse clinical outcome in COVID-19 patients |pdf=|usr=}}
| |
| − | {{tp|p=32373235|t=2020. CT quantification of pneumonia lesions in early days predicts progression to severe illness in a cohort of COVID-19 patients |pdf=|usr=}}
| |
| − | {{tp|p=32292517|t=2020. CT Scans of Patients with 2019 Novel Coronavirus (COVID-19) Pneumonia |pdf=|usr=}}
| |
| − | {{tp|p=32179123|t=ä. Clinical diagnostic value of CT imaging in COVID-19 with multiple negative RT-PCR testing |pdf=|usr=}}
| |
| − | {{tp|p=32272630|t=2020. Lung Involvement Found on Chest CT Scan in a Pre-Symptomatic Person with SARS-CoV-2 Infection: A Case Report |pdf=|usr=}}
| |
| − | {{tp|p=32299200|t=2020. Radiological approaches to COVID-19 pneumonia |pdf=|usr=}}
| |
| − | {{tp|p=32318891|t=2020. Sonographic signs and patterns of COVID-19 pneumonia |pdf=|usr=}}
| |
| − |
| |
| | *'''[[Diagnosis (other modalities)]]''' | | *'''[[Diagnosis (other modalities)]]''' |
| | | | |
| Zeile 73: |
Zeile 19: |
| | | | |
| | *'''[[Structure of covid19]]''' | | *'''[[Structure of covid19]]''' |
| − | {{tp|p=32269081|t=2020. Phylogenetic network analysis of SARS-CoV-2 genomes |pdf=|usr=}}
| |
| − | {{tp|p=32009228|t=2020. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission |pdf=|usr=}}
| |
| − | {{tp|p=32277040|t=2020. Structure of the RNA-dependent RNA polymerase from COVID-19 virus |pdf=|usr=}}
| |
| − | {{tp|p=32075877|t=2020. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation |pdf=|usr=}}
| |
| − | {{tp|p=C7152894|t=ä. A COMPREHENSIVE ANALYSIS OF GENOME COMPOSITION AND CODON USAGE PATTERNS OF EMERGING CORONAVIRUSES |pdf=|usr=}}
| |
| − | {{tp|p=C7085496|t=ä. Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV) |pdf=|usr=}}
| |
| − | {{tp|p=32218151|t=2020. Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins |pdf=|usr=}}
| |
| − | {{tp|p=32098422|t=2020. Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV |pdf=|usr=}}
| |
| − | {{tp|p=32366025|t=2020. Codon Usage and Phenotypic Divergences of SARS-CoV-2 Genes |pdf=|usr=}}
| |
| − | {{tp|p=32351056|t=2020. Decoding the evolution and transmissions of the novel pneumonia coronavirus (SARS-CoV-2 / HCoV-19) using whole genomic data |pdf=|usr=}}
| |
| | | | |
| | | | |
| | *'''[[Target binding and uptake]]''' | | *'''[[Target binding and uptake]]''' |
| − | {{tp|p=32165541|t=2020. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells |pdf=|usr=}}
| |
| − | {{tp|p=32364961|t=2020. Severe respiratory SARS-CoV2 infection: Does ACE2 receptor matter?|pdf=|usr=}}
| |
| − | {{tp|p=32245784|t=2020. A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV |pdf=|usr=}}
| |
| − | {{tp|p=32366695|t=ä. Site-specific glycan analysis of the SARS-CoV-2 spike |pdf=|usr=}}
| |
| − | {{tp|p=32132184|t=2020. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2 |pdf=|usr=}}
| |
| − | {{tp|p=32198713|t=ä. A Unique Protease Cleavage Site Predicted in the Spike Protein of the Novel Pneumonia Coronavirus (2019-nCoV) Potentially Related to Viral Transmissibility |pdf=|usr=}}
| |
| − | {{tp|p=32354022|t=2020. ACE2: The key Molecule for Understanding the Pathophysiology of Severe and Critical Conditions of COVID-19: Demon or Angel?|pdf=|usr=}}
| |
| − | {{tp|p=32365751|t=2020. The SARS-CoV-2 Exerts a Distinctive Strategy for Interacting with the ACE2 Human Receptor |pdf=|usr=}}
| |
| − |
| |
| | *'''[[Cytopathic effects]]''' | | *'''[[Cytopathic effects]]''' |
| − | {{ttp|p=32291557|t=ä. SARS-CoV-2-encoded nucleocapsid protein acts as a viral suppressor of RNA interference in cells |pdf=|usr=}}
| |
| − | {{tp|p=32347055|t=2020. Role of cyclophilin A during coronavirus replication and the antiviral activities of its inhibitors |pdf=|usr=}}
| |
| − | {{ttp|p=32368569|t=ä. The molecular biology of intracellular events during Coronavirus infection cycle |pdf=|usr=}}
| |
| | | | |
| | *'''[[Secretion and shedding]]''' | | *'''[[Secretion and shedding]]''' |
| − | {{tp|p=32304647|t=2020. SARS-CoV-2 shedding and infectivity |pdf=|usr=}}
| |
| − | {{tp|p=32304646|t=ä. SARS-CoV-2 shedding and infectivity ? Authors reply |pdf=|usr=}}
| |
| | | | |
| | | | |
| Zeile 109: |
Zeile 31: |
| | | | |
| | *'''[[Immunology]]''' | | *'''[[Immunology]]''' |
| − | {{tp|p=32292530|t=2020. Respiratory diseases, allergy and COVID-19 infection. First news from Wuhan|pdf=|usr=}}
| |
| | | | |
| | | | |
| | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' | | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' |
| − | {{tp|p=32226636|t=2020. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study |pdf=|usr=}}
| |
| − | {{tp|p=32298458|t=2020. Is antibody-dependent enhancement playing a role in COVID-19 pathogenesis?|pdf=|usr=}}
| |
| − | {{tp|p=32238976|t=2020. Cytokinstormer ved covid-19?|pdf=|usr=}}
| |
| − | {{tp|p=32321221|t=2020. Hemofagocytisk lymfohistiocytose ved covid-19?|pdf=|usr=}}
| |
| − | {{tp|p=32125642|t=ä. Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | ---- | | ---- |
| | *'''[[Pathobiology]]''' | | *'''[[Pathobiology]]''' |
| − | {{tp|p=32326988|t=ä. Lactose Dehydrogenase in Patients with Severe COVID-19: A Meta-Analysis of Retrospective Study }}
| |
| − | {{tp|p=32339247|t=ä. Does apolipoprotein E genotype predict COVID-19 severity?|pdf=|usr=}}
| |
| − | {{tp|p=32371949|t=2020. Immune dysfunction leads to mortality and organ injury in patients with COVID-19 in China: insights from ERS-COVID-19 study |pdf=|usr=}}
| |
| − | {{ttp|p=32360977|t=ä. The role of Neutrophil Extracellular Traps in Covid-19: Only an hypothesis or a potential new field of research?|pdf=|usr=}}
| |
| − | {{ttp|p=32305740|t=ä. Severe COVID-19 infection associated with endothelial activation |pdf=|usr=}}
| |
| − | {{ttp|p=32299776|t=ä. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases |pdf=|usr=}}
| |
| − | {{tp|p=32283217|t=ä. Mortality of a pregnant patient diagnosed with COVID-19: A case report with clinical, radiological, and histopathological findings |pdf=|usr=}}
| |
| − | {{tp|p=32356025|t=ä. Early histologic findings of pulmonary SARS-CoV-2 infection detected in a surgical specimen |pdf=|usr=}}
| |
| − | {{tp|p=32350596|t=ä. The autopsy debate during the COVID-19 emergency: the Italian experience |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | | | |
| | *'''[[Disease Models]]''' | | *'''[[Disease Models]]''' |
| − | {{tp|p=32303993|t=ä. Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids |pdf=|usr=}}
| |
| − | {{tp|p=32303590|t=2020. Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model |pdf=|usr=}}
| |
| | | | |
| | *'''[[Similar diseases and pathomechanisms]]''' | | *'''[[Similar diseases and pathomechanisms]]''' |
| − | {{tp|p=32342879|t=ä. COVID-19 and radiation induced pneumonitis: overlapping clinical features of different diseases |pdf=|usr=}}
| |
| − | {{tp|p=32202647|t=2020. Mimics and chameleons of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32184131|t=ä. Comparison of clinical characteristics of coronavirus disease (COVID-19) and severe acute respiratory syndrome (SARS) as experienced in Taiwan |pdf=|usr=}}
| |
| − | {{tp|p=32293833|t=2020. Emerging and reemerging respiratory viral infections up to Covid-19 |pdf=|usr=}}
| |
| − | {{tp|p=31670218|t=2020. Porcine deltacoronavirus (PDCoV) modulates calcium influx to favor viral replication |pdf=|usr=}}
| |
| − | {{tp|p=31936476|t=2020. Isolation and Identification of Porcine Deltacoronavirus and Alteration of Immunoglobulin Transport Receptors in the Intestinal Mucosa of PDCoV-Infected Piglets |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | | | |
| Zeile 155: |
Zeile 51: |
| | | | |
| | *'''[[Systemic disease, any manifestations]]''' | | *'''[[Systemic disease, any manifestations]]''' |
| − | {{tp|p=32222804|t=ä. Arthralgia as an initial presentation of COVID-19: observation |pdf=|usr=}}
| |
| − |
| |
| | *'''[[Co-Infection]]''' | | *'''[[Co-Infection]]''' |
| | {{tp|p=32192233|t=2020. Co-infection with SARS-CoV-2 and Human Metapneumovirus |pdf=|usr=}} | | {{tp|p=32192233|t=2020. Co-infection with SARS-CoV-2 and Human Metapneumovirus |pdf=|usr=}} |
| Zeile 166: |
Zeile 60: |
| | | | |
| | *'''[[Pulmonary embolism, coagulation]]''' | | *'''[[Pulmonary embolism, coagulation]]''' |
| − | {{tp|p=32356640|t=2020. SARS-CoV-2 pneumonia and pulmonary embolism in a 66-year-old female |pdf=|usr=}}
| |
| − | {{tp|p=32329980|t=2020. SARS-CoV-2 infection masquerading as a possible pulmonary embolism |pdf=|usr=}}
| |
| − | {{tp|p=32351657|t=ä. Arterial and venous abdominal thrombosis in a 79-year-old woman with COVID-19 pneumonia |pdf=|usr=}}
| |
| − | {{tp|p=32353746|t=2020. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy |pdf=|usr=}}
| |
| − | {{tp|p=32335420|t=ä. Age-adjusted D-dimer cut-off levels to rule out venous thromboembolism in COVID-19 patients |pdf=|usr=}}
| |
| − | {{tp|p=32371163|t=ä. Pulmonary embolism in a young pregnant woman with Covid-19 |pdf=|usr=}}
| |
| − | {{tp|p=32361513|t=ä. Where do we stand with antithrombotic prophylaxis in patients with COVID-19?|pdf=|usr=}}
| |
| − | {{tp|p=32302782|t=2020. Pulmonary embolism in patients with COVID-19: Time to change the paradigm of computed tomography |pdf=|usr=}}
| |
| − | {{tp|p=C7146714|t=ä. Incidence of thrombotic complications in critically ill ICU patients with COVID-19 |pdf=|usr=}}
| |
| | | | |
| | | | |
| | + | *'''[[Hematology]]''' |
| | | | |
| | | | |
| − | *'''[[Hematology]]'''
| |
| − | {{tp|p=32294340|t=ä. Immune Thrombocytopenic Purpura in a Patient with Covid-19 |pdf=|usr=}}
| |
| | | | |
| − |
| |
| − | *'''[[Microvascular]]'''
| |
| | | | |
| | *'''[[Heart]]''' | | *'''[[Heart]]''' |
| − | {{tp|p=32372844|t=ä. COVID-19 y tratamiento guiado con tests de diagn�stico bioqu�micos y moleculares para reducir el da�o cardiaco y la cardiotoxicidad |pdf=|usr=}}
| |
| − | {{tp|p=32355394|t=ä. COVID-19 y shock cardiog�nico: diferentes formas de presentaci�n cardiovascular con alta mortalidad |pdf=|usr=}}
| |
| − | {{tp|p=32345547|t=ä. Fulminant myocarditis due to COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32267110|t=2020. COVID-19 et maladies cardiovasculaires |pdf=|usr=}}
| |
| − | {{tp|p=32227794|t=2020. At the heart of the COVID-19 outbreak: early cardiac implications and mitigating strategies |pdf=|usr=}}
| |
| − | {{tp|p=32312365|t=2020. Research advances in cardiovascular system damage caused by SARS-CoV-2 in children |pdf=|usr=}}
| |
| | | | |
| | | | |
| | *'''[[Neurology, ophthalmology, orl]]''' | | *'''[[Neurology, ophthalmology, orl]]''' |
| − | {{tp|p=32329044|t=2020. Complicaciones neurologicas por coronavirus y COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32359804|t=ä. Covid-19 and Guillain-Barr� syndrome: More than a coincidence!|pdf=|usr=}}
| |
| − | {{tp|p=32334841|t=ä. COVID-19 may induce Guillain-Barr� syndrome |pdf=|usr=}}
| |
| − | {{tp|p=32246403|t=ä. The brain, another potential target organ, needs early protection from SARS-CoV-2 neuroinvasion |pdf=|usr=}}
| |
| − | {{tp|p=32344366|t=2020. Focal status epilepticus as unique clinical feature of COVID-19: A case report |pdf=|usr=}}
| |
| − | {{tp|p=32366614|t=2020. Clinical time course of COVID-19, its neurological manifestation and some thoughts on its management |pdf=|usr=}}
| |
| − | {{tp|p=32284735|t=2020. Potential neurological symptoms of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32378854|t=2020. Covid-19 med nedsatt lukte- og smakssans som eneste symptom |pdf=|usr=}}
| |
| − | {{tp|p=32298782|t=ä. Anosmia in a healthcare worker with COVID-19 in Madrid, Spain |pdf=|usr=}}
| |
| − | {{tp|p=32359765|t=ä. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System |pdf=|usr=}}
| |
| − | {{tp|p=32313712|t=ä. Anosmia, hyposmia, and dysgeusia as indicators for positive SARS-CoV-2 infection |pdf=|usr=}}
| |
| − |
| |
| | *'''[[Dermatology]]''' | | *'''[[Dermatology]]''' |
| | | | |
| | | | |
| | *'''[[Gastroenterology, hepatology]]''' | | *'''[[Gastroenterology, hepatology]]''' |
| − | {{tp|p=32328338|t=2020. Anal swab findings in an infant with COVID?19 |pdf=|usr=}}
| |
| − | {{tp|p=32356641|t=2020. Addressing multiple gastroenterological aspects of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32250094|t=2020. Gastrointestinal symptoms as the first, atypical indication of severe acute respiratory syndrome coronavirus 2 infection |pdf=|usr=}}
| |
| − | {{tp|p=32343593|t=2020. COVID-19, coronavirus, SARS-CoV-2 and the small bowel |pdf=|usr=}}
| |
| − | {{tp|p=32376072|t=ä. Beware: Gastrointestinal symptoms can be a manifestation of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32353720|t=2020. COVID-19 faecal-oral transmission: Are we asking the right questions?|pdf=|usr=}}
| |
| − | {{tp|p=32358202|t=ä. SARS-CoV-2 productively infects human gut enterocytes |pdf=|usr=}}
| |
| − | {{tp|p=32378864|t=2020. Covid-19 med akutte magesmerter som debutsymptom |pdf=|usr=}}
| |
| − | {{tp|p=32368531|t=2020. Hypertransaminasemia in the course of infection with SARS-CoV-2: Incidence and pathogenetic hypothesis |pdf=|usr=}} ''hellp''
| |
| − |
| |
| | *'''[[Kidney, urology]]''' | | *'''[[Kidney, urology]]''' |
| − | {{tp|p=32362571|t=2020. SARS-CoV-2 and the testis: similarity with other viruses and routes of infection |pdf=|usr=}}
| |
| − | {{tp|p=32343996|t=ä. Rising Concern on Damaged Testis of COVID-19 Patients |pdf=|usr=}}
| |
| − | {{tp|p=32318855|t=ä. Does COVID-19 affect male fertility?|pdf=|usr=}}
| |
| | | | |
| | | | |
| | *'''[[Risk and special populations]]''' | | *'''[[Risk and special populations]]''' |
| − | {{tp|p=C7129713|t=ä. Coronavirus: la emergencia geri�trica de 2020 Documento conjunto de la Secci�n de Cardiolog�a Geri�trica de la Sociedad Espa�ola de Cardiolog�a y la Sociedad Espa�ola de Geriatr�a y Gerontolog�a |pdf=|usr=}}
| |
| − | {{tp|p=C7151242|t=ä. Controversy regarding ACE inhibitors / ARBs in Covid-19 |pdf=|usr=}}
| |
| − | {{tp|p=32331829|t=ä. Smoking and coronavirus disease 2019 (COVID-19) |pdf=|usr=}}
| |
| − | {{tp|p=32362357|t=ä. Patients with MS treated with immunosuppressive agents: Across the COVID-19 spectrum |pdf=|usr=}}
| |
| − | {{tp|p=32314010|t=ä. Coronavirus Disease 19 (COVID-19) complicated with pneumonia in a patient with rheumatoid arthritis receiving conventional disease-modifying antirheumatic drugs |pdf=|usr=}}
| |
| − | {{tp|p=32346493|t=ä. Clinical presentations and outcomes of SARS-CoV-2 infected pneumonia in pregnant women and health status of their neonates |pdf=|usr=}}
| |
| − | {{tp|p=32335406|t=ä. Factors associated with negative conversion of viral RNA in patients hospitalized with COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32336968|t=2020. COVID-19 outbreak impact in Spain: A role for tobacco smoking?|pdf=|usr=}}
| |
| − | {{tp|p=32206052|t=2020. COVID-19 and smoking: A systematic review of the evidence |pdf=|usr=}}
| |
| − | {{tp|p=32355638|t=ä. Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system |pdf=|usr=}}
| |
| − | {{tp|p=32154135|t=2020. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia |pdf=|usr=}}
| |
| − | {{tp|p=32247017|t=ä. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and COVID-19 infection during pregnancy |pdf=|usr=}}
| |
| − | {{tp|p=32314274|t=ä. Clinical Manifestation and Laboratory Characteristics of SARS-CoV-2 Infection in Pregnant Women |pdf=|usr=}}
| |
| − | {{tp|p=32050635|t=2020. Potential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections |pdf=|usr=}}
| |
| − | {{tp|p=32204755|t=2020. SARS-CoV-2 infection with gastrointestinal symptoms as the first manifestation in a neonate |pdf=|usr=}}
| |
| | | | |
| | *'''[[The morbid survivor]]''' | | *'''[[The morbid survivor]]''' |
| − | {{tp|p=32360909|t=ä. Follow-up studies in COVID-19 recovered patients - is it mandatory?|pdf=|usr=}}
| |
| | | | |
| | *'''[[Case reports]]''' | | *'''[[Case reports]]''' |
| − | {{tp|p=32312026|t=2020. An elderly couple with COVID-19 pneumonia treated in Singapore: contrasting clinical course and management |pdf=|usr=}}
| |
| − | {{tp|p=32277836|t=2020. Benign COVID-19 in an immunocompromised cancer patient - the case of a married couple |pdf=|usr=}}
| |
| − | {{tp|p=32321232|t=2020. En mann i 90-arene med feber og torrhoste |pdf=|usr=}}
| |
| − | {{tp|p=32378842|t=2020. Covid-19 med stille hypoksemi |pdf=|usr=}}
| |
| − | {{tp|p=32355447|t=2020. The first confirmed case of COVID-19 in Tanzania: recommendations based on lesson learned from China |pdf=|usr=}}
| |
| − | {{tp|p=32308532|t=2020. First COVID-19 infections in the Philippines: a case report |pdf=|usr=}}
| |
| − | {{tp|p=32293831|t=2020. Critically ill COVID-19 patient |pdf=|usr=}}
| |
| − | {{tp|p=32339558|t=ä. Asymptomatic COVID-19 Infection in a Patient Evaluated for Ureteric Colic: Radiological Findings and Impact on Management |pdf=|usr=}}
| |
| − | {{tp|p=32289085|t=2020. A novel presentation of COVID-19 via community acquired infection |pdf=|usr=}}
| |
| − | {{tp|p=32337201|t=2020. Atypical presentation of SARS-CoV-2 infection: A case report |pdf=|usr=}}
| |
| − | {{tp|p=32180140|t=ä. Clinical features of pediatric patients with COVID-19: a report of two family cluster cases |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Case series]]''' | | *'''[[Case series]]''' |
| − | {{tp|p=32146694|t=ä. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China |pdf=|usr=}}
| |
| − | {{ttp|p=32048163|t=2020. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury |pdf=|usr=}}
| |
| | *'''[[Registries]]''' | | *'''[[Registries]]''' |
| − | {{tp|p=32378844|t=2020. Covid-19: Symptomer, forlop og bruk av kliniske skaringsverktoy hos de 42 forste pasientene innlagt pa et norsk lokalsykehus |pdf=|usr=}}
| |
| − | {{tp|p=32114074|t=ä. Clinical characteristics of laboratory confirmed positive cases of SARS-CoV-2 infection in Wuhan, China: A retrospective single center analysis |pdf=|usr=}}
| |
| − | {{tp|p=32272197|t=ä. New clinical experiences and evaluation of clinical and paraclinical features of deceased patients with COVID-19 infection referred to Shahid Mostafa Khomeini Hospital of Ilam, Iranin |pdf=|usr=}}
| |
| − | {{tp|p=32247926|t=ä. Clinical features of the first cases and a cluster of Coronavirus Disease 2019 (COVID-19) in Bolivia imported from Italy and Spain |pdf=|usr=}}
| |
| − | {{tp|p=32034637|t=ä. Clinical Features and Treatment of 2019-nCov Pneumonia Patients in Wuhan: Report of A Couple Cases |pdf=|usr=}}
| |
| − | {{tp|p=32296544|t=2020. An emergent clade of SARS-CoV-2 linked to returned travellers from Iran |pdf=|usr=}}
| |
| − | {{tp|p=32318325|t=ä. The clinical data from 19 critically ill patients with coronavirus disease 2019: a single-centered, retrospective, observational study |pdf=|usr=}}
| |
| − | {{tp|p=32312364|t=2020. Clinical features of children with SARS-CoV-2 infection: an analysis of 13 cases from Changsha, China |pdf=|usr=}}
| |
| − | {{tp|p=32312363|t=2020. Clinical features of children with SARS-CoV-2 infection: an analysis of 115 cases |pdf=|usr=}}
| |
| − | {{tp|p=32204756|t=2020. Clinical features and chest CT findings of coronavirus disease 2019 in infants and young children |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| | ---- | | ---- |
| | | | |
| | | | |
| | *'''[[Trials]]''' | | *'''[[Trials]]''' |
| − | {{ttp|p=C7156793|t=2020. COVID-19 randomised trial protocols: rapid publication without barriers |pdf=|usr=}}
| |
| − | {{tp|p=32292826|t=2020. A living systematic review protocol for COVID-19 clinical trial registrations |pdf=|usr=}}
| |
| | | | |
| | *'''[[Candidate Compounds Covid19]]''' | | *'''[[Candidate Compounds Covid19]]''' |
| − | {{tp|p=32239125|t=2020. Remdesivir, la esperanza antiviral frente al SARS-CoV-2 |pdf=|usr=}}
| |
| − | {{tp|p=32256547|t=2020. Clinical trials on drug repositioning for COVID-19 treatment |pdf=|usr=}}
| |
| − | {{tp|p=32267301|t=ä. Driving forces for COVID-19 clinical trials using chloroquine: the need to choose the right research questions and outcomes |pdf=|usr=}}
| |
| − | {{tp|p=32232552|t=ä. Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs |pdf=|usr=}}
| |
| − | {{tp|p=32124179|t=ä. Clinical trials for the treatment of Coronavirus disease 2019 (COVID-19): A rapid response to urgent need |pdf=|usr=}}
| |
| − | {{tp|p=32376987|t=2020. Inhibition of Influenza A virus propagation by benzoselenoxanthenes stabilizing TMPRSS2 Gene G-quadruplex and hence down-regulating TMPRSS2 expression |pdf=|usr=}}
| |
| − | {{tp|p=32278175|t=ä. COVID-19: A promising cure for the global panic |pdf=|usr=}}
| |
| − | {{tp|p=32253226|t=ä. (β-D-N4-hydroxycytidine (NHC, EIDD-1931) An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice |pdf=|usr=}}
| |
| − | {{tp|p=32358203|t=ä. Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir |pdf=|usr=}}
| |
| − | {{tp|p=32198291|t=2020. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved ?-ketoamide inhibitors |pdf=|usr=}}
| |
| − | {{tp|p=32321856|t=ä. Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease |pdf=|usr=}}
| |
| − | {{tp|p=32347055|t=2020. Role of cyclophilin A during coronavirus replication and the antiviral activities of its inhibitors |pdf=|usr=}}
| |
| − | {{tp|p=32341331|t=2020. A retrospective cohort study of methylprednisolone therapy in severe patients with COVID-19 pneumonia |pdf=|usr=}}
| |
| − | {{tp|p=32347054|t=2020. Strategies for vaccine development of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32133159|t=2020. Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia |pdf=|usr=}}
| |
| − | {{tp|p=32366290|t=2020. Mesenchymal stem cells as a potential therapy for COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=C7110269|t=ä. COVID-19 Outbreak: an Update on Therapeutic Options |pdf=|usr=}}
| |
| − | {{tp|p=32307653|t=ä. CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement |pdf=|usr=}}
| |
| − | {{tp|p=32281052|t=ä. Mesenchymal Stem Cell Therapy for COVID-19: Present or Future |pdf=|usr=}}
| |
| − | {{tp|p=32320535|t=2020. Mesenchymal stem cells as a potential treatment for critically ill patients with coronavirus disease 2019 |pdf=|usr=}}
| |
| − | {{tp|p=32362735|t=ä. Insights into the inhibitory potential of selective phytochemicals against Mpro of 2019-nCoV: a computer-aided study |pdf=|usr=}}
| |
| − | {{tp|p=32347963|t=2020. An independent appraisal and re-analysis of hydroxychloroquine treatment trial for COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32343358|t=2020. Immunoglobulins or convalescent plasma to tackle COVID-19: buying time to save lives - current situation and perspectives |pdf=|usr=}}
| |
| − | {{tp|p=32328234|t=2020. Does the direct renin inhibitor have a role to play in attenuating severity of the outbreak coronavirus disease 2019 (COVID-19)?|pdf=|usr=}}
| |
| − | {{tp|p=32360140|t=ä. Bee venom and SARS-CoV-2 |pdf=|usr=}}
| |
| − | {{tp|p=32345485|t=ä. Treatment for emerging viruses: Convalescent plasma and COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32359789|t=ä. COVID-19 Convalescent Plasma: Now Is the Time for Better Science |pdf=|usr=}}
| |
| − | {{tp|p=32359788|t=ä. Convalescent Plasma: Therapeutic Hope or Hopeless Strategy in the SARS-CoV-2 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32289548|t=2020. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study |pdf=|usr=}}
| |
| − | {{tp|p=32247925|t=ä. Repurposing antimalarials and other drugs for COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32145386|t=ä. Remdesivir as a possible therapeutic option for the COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32334088|t=ä. SARS-CoV-2 and COVID-19: What are our options? Where should we focus our attention on to find new drugs and strategies?|pdf=|usr=}}
| |
| − | {{tp|p=32325121|t=ä. Tocilizumab: A new opportunity in the possible therapeutic arsenal against COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32247927|t=ä. Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence |pdf=|usr=}}
| |
| − | {{tp|p=32249063|t=ä. Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses |pdf=|usr=}}
| |
| − | {{tp|p=32362491|t=ä. Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses: (Trends in Immunology 41, 355?359; 2020) |pdf=|usr=}}
| |
| − | {{tp|p=32294562|t=ä. A search for medications to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2 spike glycoprotein and 3CL protease |pdf=|usr=}}
| |
| − | {{tp|p=32371057|t=ä. Potential applications of plant biotechnology against SARS-CoV-2 |pdf=|usr=}}
| |
| − | {{tp|p=32291112|t=ä. Ongoing Clinical Trials for the Management of the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32299202|t=2020. COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs|pdf=|usr=}}
| |
| − | {{tp|p=32293834|t=2020. Antiviral treatment of COVID-19|pdf=|usr=}}
| |
| − | {{tp|p=32295153|t=2020. What Does Plant-Based Vaccine Technology Offer to the Fight against COVID-19?|pdf=|usr=}}
| |
| − | {{tp|p=32235387|t=2020. Progress and Prospects on Vaccine Development against SARS-CoV-2 |pdf=|usr=}}
| |
| − | {{tp|p=32034638|t=ä. Compensation of ACE2 Function for Possible Clinical Management of 2019-nCoV-Induced Acute Lung Injury |pdf=|usr=}}
| |
| − | {{tp|p=32297156|t=ä. Computational Identification of Small Interfering RNA Targets in SARS-CoV-2 |pdf=|usr=}}
| |
| − | {{tp|p=32360300|t=ä. Natural product-derived phytochemicals as potential agents against coronaviruses: a review |pdf=|usr=}}
| |
| − | {{tp|p=32363219|t=ä. Binding site analysis of potential protease inhibitors of COVID-19 using AutoDock |pdf=|usr=}}
| |
| − | {{tp|p=32106567|t=2020. Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies |pdf=|usr=}}
| |
| − | {{tp|p=32098094|t=2020. Structural Basis for Inhibiting Porcine Epidemic Diarrhea Virus Replication with the 3C-Like Protease Inhibitor GC376 |pdf=|usr=}}
| |
| − | {{tp|p=32272550|t=2020. Antiviral Agents: Discovery to Resistance |pdf=|usr=}}
| |
| − | {{tp|p=32268515|t=2020. In Silico Discovery of Candidate Drugs against Covid-19 |pdf=|usr=}}
| |
| − | {{tp|p=32357553|t=2020. Repurposing Antiviral Protease Inhibitors Using Extracellular Vesicles for Potential Therapy of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32340120|t=2020. Shedding Light on the Effect of Natural Anti-Herpesvirus Alkaloids on SARS-CoV-2: A Treatment Option for COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32295237|t=2020. Molecular Investigation of SARS-CoV-2 Proteins and Their Interactions with Antiviral Drugs |pdf=|usr=}}
| |
| − | {{tp|p=32313883|t=2020. Inhaled biguanides and mTOR inhibition for influenza and coronavirus (Review) |pdf=|usr=}}
| |
| − | {{tp|p=C7118592|t=ä. Understanding of guidance for acupuncture and moxibustion interventions on COVID-19 (Second edition) issued by CAAM |pdf=|usr=}}
| |
| − | {{ttp|p=32312290|t=2020. Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markov decision analysis |pdf=|usr=}}
| |
| − |
| |
| | ---- | | ---- |
| | | | |
| | | | |
| | *'''[[Other routes of infection]]''' | | *'''[[Other routes of infection]]''' |
| − | {{tp|p=32291098|t=ä. Assessing Viral Shedding and Infectivity of Tears in Coronavirus Disease 2019 (COVID-19) Patients |pdf=|usr=}}
| |
| − | {{tp|p=32333379|t=2020. COVID-19 and Semen: An Unanswered Area of Research |pdf=|usr=}}
| |
| | | | |
| | | | |
| Zeile 354: |
Zeile 101: |
| | | | |
| | *'''[[Passive protective equipment]]''' | | *'''[[Passive protective equipment]]''' |
| − | {{ttp|p=32322159|t=ä. Electrostatic Charged Nanofiber Filter for Filtering Airborne Novel Coronavirus (COVID-19) and Nano-aerosols |pdf=|usr=}}
| |
| − | {{ttp|p=32372877|t=2020. Charged PVDF multilayer nanofiber filter in filtering simulated airborne novel coronavirus (COVID-19) using ambient nano-aerosols |pdf=|usr=}}
| |
| − | {{tp|p=32335209|t=ä. Correspondence: Angiotensin-converting enzyme 2 coated nanoparticles containing respiratory masks, chewing gums and nasal filters may be used for protection against COVID-19 infection |pdf=|usr=}}
| |
| | | | |
| | *'''[[Running your hospital]]''' | | *'''[[Running your hospital]]''' |
| − | {{tp|p=32372843|t=ä. Telecardiolog�a en tiempos de la pandemia COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32338017|t=2020. COVID-19 and the digestive system: protection and management during the SARS-CoV-2 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32316737|t=2020. Resumption of activity in gastroenterology departments Recommendations by SEPD, AEEH, GETECCU and AEG |pdf=|usr=}}
| |
| − | {{tp|p=32202911|t=2020. Recommendations by the SEPD and AEG, both in general and on the operation of gastrointestinal endoscopy and gastroenterology units, concerning the current SARS-CoV-2 pandemic (March, 18) |pdf=|usr=}}
| |
| − | {{tp|p=32329046|t=2020. Documento EMCAM (Esclerosis Multiple Comunidad Autonoma de Madrid) para el manejo de pacientes con esclerosis multiple durante la pandemia de SARS-CoV-2 |pdf=|usr=}}
| |
| − | {{tp|p=32329045|t=2020. Herramientas de salud digital para superar la brecha de atencion en epilepsia antes, durante y despues de la pandemia de COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32303331|t=2020. Covid-19, the pandemic war: Implication for neurologists |pdf=|usr=}}
| |
| − | {{tp|p=32354651|t=ä. Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network |pdf=|usr=}}
| |
| − | {{tp|p=32320999|t=2020. CHALLENGES IN THE FIGHT AGAINST THE COVID-19 PANDEMIC IN UNIVERSITY HOSPITALS |pdf=|usr=}}
| |
| − | {{ttp|p=C7102575|t=ä. Preventing intra-hospital infection and transmission of COVID-19 in healthcare workers |pdf=|usr=}}
| |
| − | {{tp|p=32292260|t=2020. Guidelines for dental care provision during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32341229|t=2020. Saudi association for the study of liver diseases and transplantation position statement on liver transplantation during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32343342|t=ä. The COVID-19 Global Pandemic: Implications for People With Schizophrenia and Related Disorders |pdf=|usr=}}
| |
| − | {{tp|p=32345478|t=ä. Is schizophrenia research relevant during the COVID-19 pandemic?|pdf=|usr=}}
| |
| − | {{tp|p=32349886|t=ä. Long-acting injectable antipsychotics treatment during COVID-19 pandemic ? A new challenge |pdf=|usr=}}
| |
| − | {{tp|p=32299718|t=ä. Ecosystem approaches to the risk for schizophrenia |pdf=|usr=}}
| |
| − | {{tp|p=32327314|t=ä. COVID-19, mobile health and serious mental illness |pdf=|usr=}}
| |
| − | {{tp|p=32370129|t=2020. Blockchain-Based Healthcare Workflow for Tele-Medical Laboratory in Federated Hospital IoT Clouds |pdf=|usr=}}
| |
| − | {{tp|p=32349198|t=2020. Chapter of Gastroenterologists professional guidance for management of patients with liver disease in Singapore during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32241064|t=2020. A call to arms: a perspective of safe general surgery in Singapore during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32241065|t=2020. Chapter of Gastroenterologists professional guidance on risk mitigation for gastrointestinal endoscopy during COVID-19 pandemic in Singapore |pdf=|usr=}}
| |
| − | {{tp|p=32227793|t=2020. Dealing with COVID-19: initial perspectives of a small radiology department |pdf=|usr=}}
| |
| − | {{tp|p=32349195|t=2020. Deeply reconsidering elective surgery: worldwide concerns regarding colorectal surgery in a COVID-19 pandemic and a Singapore perspective |pdf=|usr=}}
| |
| − | {{tp|p=32312024|t=2020. Trauma and orthopaedics in the COVID-19 pandemic: breaking every wave |pdf=|usr=}}
| |
| − | {{tp|p=32299184|t=2020. COVID-19 - where do we go from here?|pdf=|usr=}}
| |
| − | {{tp|p=32299183|t=2020. Striving as a nation to become an academic leader in the COVID-19 crisis |pdf=|usr=}}
| |
| − | {{tp|p=32283886|t=2020. Love in the time of coronavirus: training and service during COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32279480|t=2020. Impact of COVID 19: perspectives from gastroenterology |pdf=|usr=}}
| |
| − | {{tp|p=32361216|t=2020. Sleep problems and medical isolation during the SARS-CoV-2 outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32361215|t=2020. Delirium and sleep disturbances in COVID?19: a possible role for melatonin in hospitalized patients?|pdf=|usr=}}
| |
| − | {{tp|p=32371939|t=ä. Impact of COVID-19 outbreak on spinal pathology: single center first impression |pdf=|usr=}}
| |
| − | {{tp|p=32346122|t=2020. Lessons learned from the coronavirus disease 2019 (Covid-19) outbreak in a monographic center for spinal cord injury |pdf=|usr=}}
| |
| − | {{tp|p=32317765|t=ä. COVID-19: the risk of respiratory techniques in healthcare workers |pdf=|usr=}}
| |
| − | {{tp|p=32303672|t=2020. COVID-19 tsunami: the first case of a spinal cord injury patient in Italy |pdf=|usr=}}
| |
| − | {{tp|p=32344060|t=ä. Spine Fellowship Training Reorganizing during a Pandemic: Perspectives from a Tertiary Orthopaedic Specialty Center in the Epicenter of Outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32296046|t=2020. COVID-19 and spinal cord injury and disease: results of an international survey |pdf=|usr=}}
| |
| − | {{tp|p=32243846|t=2020. Message from the Editor: Stem Cell Science in the Time of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32352910|t=2020. Endovascular Therapy for Patients With Acute Ischemic Stroke During the COVID-19 Pandemic: A Proposed Algorithm |pdf=|usr=}}
| |
| − | {{tp|p=32347790|t=2020. Mechanical Thrombectomy in the Era of the COVID-19 Pandemic: Emergency Preparedness for Neuroscience Teams: A Guidance Statement From the Society of Vascular and Interventional Neurology |pdf=|usr=}}
| |
| − | {{tp|p=32323016|t=ä. SAGES and EAES recommendations for minimally invasive surgery during COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32363070|t=2020. Even with COVID-19 neurosurgeons should still perform necessary urgent/emergent neurosurgery to avoid major permanent neurological deficits |pdf=|usr=}}
| |
| − | {{tp|p=32363053|t=2020. COVID-19 Provides An Opportunity to Reassess How Frequent and How Extensive Elective Spine Surgery Should Be |pdf=|usr=}}
| |
| − | {{tp|p=32367447|t=ä. (Laparoscopy)Detect to protect: pneumoperitoneum gas samples for SARS-CoV-2 and biohazard testing |pdf=|usr=}}
| |
| − | {{tp|p=32307095|t=ä. Response to COVID-19 by the surgical community |pdf=|usr=}}
| |
| − | {{tp|p=32299626|t=ä. COVID-19: How can a department of general surgery survive in a pandemic?|pdf=|usr=}}
| |
| − | {{tp|p=32208497|t=2020. COVID-19 pandemic: palliative care for elderly and frail patients at home and in residential and nursing homes |pdf=|usr=}}
| |
| − | {{tp|p=32208494|t=2020. COVID-19: decision making and palliative care |pdf=|usr=}}
| |
| − | {{tp|p=32208495|t=2020. COVID-19 pandemic: triage for intensive-care treatment under resource scarcity |pdf=|usr=}}
| |
| − | {{tp|p=32208493|t=2020. Recommendations for the admission of patients with COVID-19 to intensive care and intermediate care units (ICUs and IMCUs) |pdf=|usr=}}
| |
| − | {{tp|p=32352150|t=2020. Age, comorbidity, frailty status: effects on disposition and resource allocation during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32271935|t=2020. Response of a European surgical department to the COVID-19 crisis |pdf=|usr=}}
| |
| − | {{tp|p=32330285|t=2020. Interventional radiology workflow during the COVID-19 pandemic: recommendations of the Swiss Society of Vascular and Interventional Radiology |pdf=|usr=}}
| |
| − | {{tp|p=32304488|t=ä. Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug?Drug Interactions |pdf=|usr=}}
| |
| − | {{tp|p=32291968|t=2020. Recommendations of individualized medical treatment and common adverse events management for lung cancer patients during the outbreak of COVID-19 epidemic |pdf=|usr=}}
| |
| − | {{tp|p=32291939|t=2020. Preliminary recommendations for lung surgery during COVID-19 epidemic period |pdf=|usr=}}
| |
| − | {{tp|p=32336956|t=2020. Thrombosis management in times of COVID-19 epidemy; a Dutch perspective |pdf=|usr=}}
| |
| − | {{tp|p=32107119|t=ä. Coronavirus Disease 2019: Coronaviruses and Blood Safety |pdf=|usr=}}
| |
| − | {{tp|p=32147378|t=ä. COVID-19 and Blood Safety: Help with a Dilemma |pdf=|usr=}}
| |
| − | {{tp|p=32284222|t=2020. The active role of a blood center in outpacing the transfusion transmission of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32205268|t=ä. Buffer areas in emergency department to handle potential COVID-19 community infection in Taiwan |pdf=|usr=}}
| |
| − | {{tp|p=32205269|t=ä. Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, - January 31st to March 1st, 2020: A respiratory virus snapshot |pdf=|usr=}}
| |
| − | {{tp|p=32368620|t=2020. Performing tracheostomy during the Covid-19 pandemic: guidance and recommendations from the Critical Care and Acute Care Surgery Committees of the American Association for the Surgery of Trauma |pdf=|usr=}}
| |
| − | {{tp|p=32371150|t=ä. Immediate impact of COVID-19 on transplant activity in the Netherlands |pdf=|usr=}}
| |
| − | {{tp|p=32283216|t=ä. COVID-19 in a tertiary hospital from Romania: Epidemiology, preparedness and clinical challenges |pdf=|usr=}}
| |
| − | {{tp|p=32316857|t=2020. COVID-19 and orthopaedic surgeons: the Indian scenario |pdf=|usr=}}
| |
| − | {{tp|p=32299205|t=2020. Protective measures for COVID-19 for healthcare providers and laboratory personnel |pdf=|usr=}}
| |
| − | {{tp|p=32327199|t=ä. World Federation for Ultrasound in Medicine and Biology Position Statement: How to Perform a Safe Ultrasound Examination and Clean Equipment in the Context of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32281517|t=2020. The daily impact of COVID-19 in gastroenterology |pdf=|usr=}}
| |
| − | {{tp|p=32328880|t=ä. What happened to surgical emergencies in the era of COVID-19 outbreak? Considerations of surgeons working in an Italian COVID-19 red zone |pdf=|usr=}}
| |
| − | {{tp|p=32207541|t=2020. COVID-19, Urologists and Hospitals |pdf=|usr=}}
| |
| − | {{tp|p=32207540|t=2020. Urology practice in the time of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32296888|t=2020. Urologie in der Corona-Virus-Pandemie ? Leitfaden�4/20 |pdf=|usr=}}
| |
| − | {{tp|p=32360121|t=ä. Preserving Operational Capability while Building Capacity during the COVID-19 Pandemic: A Tertiary Urology Centre s Experience |pdf=|usr=}}
| |
| − | {{tp|p=32339561|t=ä. Considerations for Bedside Urologic Procedures in Patients with Severe Acute Respiratory Syndrome Coronavirus-2 |pdf=|usr=}}
| |
| − | {{tp|p=32330533|t=ä. Telemedicine and eConsults for Hospitalized Patients During COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32333991|t=ä. The Use of Captopril?Angiotensin Converting Enzyme (ACE) Inhibitor for Cystinuria During COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32339555|t=ä. Adapting Urology Residency Training in the COVID-19 Era |pdf=|usr=}}
| |
| − | {{tp|p=32330531|t=ä. Managing Urology Consultations during COVID-19 Pandemic: Application of a Structured Care Pathway |pdf=|usr=}}
| |
| − | {{tp|p=32247725|t=ä. Cleveland Clinic Akron General Urology Residency Program s COVID-19 Experience |pdf=|usr=}}
| |
| − | {{tp|p=32298686|t=2020. Teleurology in the Time of Covid-19 Pandemic: Here to Stay?|pdf=|usr=}}
| |
| − | {{tp|p=32289084|t=2020. COVID-19 Personal Protective Equipment (PPE) for the emergency physician |pdf=|usr=}}
| |
| − | {{tp|p=32191174|t=2020. 2019-nCoV: The Identify-Isolate-Inform (3I) Tool Applied to a Novel Emerging Coronavirus |pdf=|usr=}}
| |
| − | {{tp|p=32348064|t=2020. Hearing the Call of Duty: What We Must Do to Allow Medical Students to Respond to the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32371048|t=ä. Mental health care for pregnant women in the COVID-19 outbreak is urgently needed |pdf=|usr=}}
| |
| − | {{tp|p=32276778|t=ä. Caring for the carers: Ensuring the provision of quality maternity care during a global pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32264898|t=2020. Surgery in COVID-19 patients: operational directives |pdf=|usr=}}
| |
| − | {{tp|p=32368528|t=2020. Prevention program for the COVID-19 in a children?s digestive endoscopy center |pdf=|usr=}}
| |
| − | {{tp|p=32272957|t=2020. COVID-19 the showdown for mass casualty preparedness and management: the Cassandra Syndrome |pdf=|usr=}}
| |
| − | {{tp|p=C7128200|t=ä. Suggestions on the prevention of COVID-19 for health care workers in department of otorhinolaryngology head and neck surgery |pdf=|usr=}}
| |
| − | {{tp|p=32112336|t=ä. Management strategies of neonatal jaundice during the coronavirus disease 2019 outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32246185|t=ä. We Asked the Experts: Covid-19 Outbreak: Is There Still a Place for Scheduled Surgery? ?Reflection from Pathophysiological Data? |pdf=|usr=}}
| |
| − | {{tp|p=32335692|t=ä. Aerosol box, An Operating Room Security Measure in COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32335691|t=ä. We Asked the Experts: How Do We Maintain Surgical Quality Standards for Enhanced Recovery Programs After Cancer Surgery During the COVID-19 Outbreak?|pdf=|usr=}}
| |
| − | {{tp|p=32356225|t=ä. Intravesical therapy for bladder cancer in the pandemic of Covid-19 |pdf=|usr=}}
| |
| − | {{tp|p=32360733|t=ä. COVID-19 and Neurosurgery Literature and Neurosurgical Societies Recommendations Update |pdf=|usr=}}
| |
| − | {{tp|p=32360732|t=ä. The Management Of Neurosurgical Patients During The Covid-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32353537|t=ä. COVID-19 outbreak: single center experience in neurosurgical and neuroradiological emergency network tailoring |pdf=|usr=}}
| |
| − | {{tp|p=32344143|t=ä. Patients with Coronavirus 2019 (COVID-19) and Surgery: Guidelines and Checklist Proposal |pdf=|usr=}}
| |
| − | {{tp|p=32344132|t=ä. Lessons from China When Performing Neurosurgical Procedures During the Coronavirus Disease 2019 (COVID-19) Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32236694|t=ä. Geriatrie in Zeiten von Corona |pdf=|usr=}}
| |
| − | {{tp|p=32355606|t=ä. COVID-19 and digital epidemiology |pdf=|usr=}}
| |
| − | {{tp|p=32342184|t=ä. Aktuelle Handlungsempfehlungen der Deutschen Gesellschaft f�r Rheumatologie f�r die Betreuung von Patienten mit rheumatischen Erkrankungen w�hrend der SARS-CoV?2/Covid�19-Pandemie |pdf=|usr=}}
| |
| − | {{tp|p=32303821|t=ä. Einstellung von Patienten mit entz�ndlich-rheumatischen Erkrankungen zur immunsuppressiven Therapie im Rahmen der COVID-19 Pandemie ? eine Situationsanalyse |pdf=|usr=}}
| |
| − | {{tp|p=32312362|t=2020. Recommendations on the identification and transfer of children with critical diabetes during the COVID-19 outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32360121|t=ä. Preserving Operational Capability while Building Capacity during the COVID-19 Pandemic: A Tertiary Urology Centre s Experience |pdf=|usr=}}
| |
| − | {{tp|p=32339561|t=ä. Considerations for Bedside Urologic Procedures in Patients with Severe Acute Respiratory Syndrome Coronavirus-2 |pdf=|usr=}}
| |
| − | {{tp|p=32354693|t=ä. COVID-19, head and neck cancer, and the need of training of health students and practitioners regarding to tobacco control and patient counseling |pdf=|usr=}}
| |
| | | | |
| | *'''[[Mental aspects of health professionals]]''' | | *'''[[Mental aspects of health professionals]]''' |
| − | {{tp|p=32333109|t=ä. COVID-19 outbreak situation and its psychological impact among surgeon in training in France |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| | | | |
| | | | |
| Zeile 479: |
Zeile 113: |
| | | | |
| | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' | | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' |
| − | {{tp|p=32336835|t=ä. From the Editor of Sexuality and Disability: The Impact of COVID-19 on Sexuality and Disability?Are We Closer or More Isolated?|pdf=|usr=}}
| |
| − | {{tp|p=32241071|t=2020. Narrative synthesis of psychological and coping responses towards emerging infectious disease outbreaks in the general population: practical considerations for the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32348867|t=ä. Psychosocial impact of COVID-19 outbreak on international students living in Hubei province, China |pdf=|usr=}}
| |
| − | {{tp|p=32294713|t=2020. Personality differences and COVID-19: are extroversion and conscientiousness personality traits associated with engagement with containment measures?|pdf=|usr=}}
| |
| − | {{tp|p=32149049|t=2020. Fear can be more harmful than the severe acute respiratory syndrome coronavirus 2 in controlling the corona virus disease 2019 epidemic |pdf=|usr=}}
| |
| − | {{tp|p=32378371|t=2020. Paternal Behaviors in the Era of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32233168|t=2020. Mental Health and Psychological Intervention Amid COVID-19 Outbreak: Perspectives from South Korea |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Avoiding clinical medicine in other diseases]]''' | | *'''[[Avoiding clinical medicine in other diseases]]''' |
| − | {{tp|p=32283124|t=ä. Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States during COVID-19 Pandemic |pdf=|usr=}}
| |
| | | | |
| | | | |
| Zeile 496: |
Zeile 121: |
| | | | |
| | *'''[[Economic aspects of the status hygienicus]]''' | | *'''[[Economic aspects of the status hygienicus]]''' |
| − | {{tp|p=32242087|t=ä. What the stock market tells us about the post-COVID-19 world |pdf=|usr=}}
| |
| − | {{tp|p=32313382|t=ä. Can Global Pharmaceutical Supply Chains Scale Up Sustainably for the COVID-19 Crisis?|pdf=|usr=}}
| |
| − | {{tp|p=32313383|t=2020. A brave new world: Lessons from the COVID-19 pandemic for transitioning to sustainable supply and production |pdf=|usr=}}
| |
| − | {{tp|p=32304970|t=2020. Challenges and solutions for addressing critical shortage of supply chain for personal and protective equipment (PPE) arising from Coronavirus disease (COVID19) pandemic ? Case study from the Republic of Ireland |pdf=|usr=}}
| |
| − | {{tp|p=32341781|t=2020. Keeping alive enterprises while embracing unprecedented COVID-19 restrictions |pdf=|usr=}}
| |
| − | {{tp|p=32288597|t=2020. Predicting the impacts of epidemic outbreaks on global supply chains: A simulation-based analysis on the coronavirus outbreak (COVID-19/SARS-CoV-2) case |pdf=|usr=}}
| |
| − | {{tp|p=32272198|t=ä. COVID-19 pandemic and economic cost; impact on forcibly displaced people |pdf=|usr=}}
| |
| − | {{tp|p=32288230|t=2020. Will the COVID-19 pandemic make us reconsider the relevance of short food supply chains and local productions?|pdf=|usr=}}
| |
| − | {{tp|p=32283903|t=2020. Global threat of COVID 19 and evacuation of the citizens of different countries |pdf=|usr=}}
| |
| − | {{tp|p=32283904|t=2020. The early impact of the Covid-19 pandemic on the global and Turkish economy |pdf=|usr=}}
| |
| − | {{tp|p=32336803|t=2020. Projektion der COVID-19-Epidemie in Deutschland |pdf=|usr=}}
| |
| − | {{tp|p=32336802|t=2020. Corona-Krise: (Wirtschafts-)politische Perspektiven: Die Reflexe aus der Finanzkrise sind nicht genug!|pdf=|usr=}}
| |
| − | {{tp|p=32336801|t=2020. Wirtschaftliche Implikationen der Corona-Krise und wirtschaftspolitische Ma�nahmen |pdf=|usr=}}
| |
| − | {{tp|p=32362711|t=2020. The ?Heart Kuznets Curve?? Understanding the relations between economic development and cardiac conditions |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| | *'''[[Educational aspects of the status hygienicus]]''' | | *'''[[Educational aspects of the status hygienicus]]''' |
| − | {{tp|p=32313309|t=ä. Education and the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32302818|t=2020. Impact Of Sars-Cov-2 And Its Reverberation In Global Higher Education And Mental Health |pdf=|usr=}}
| |
| − | {{tp|p=32289547|t=ä. Online learning in the time of COVID-19 |pdf=|usr=}}
| |
| | ---- | | ---- |
| | | | |
| | | | |
| | *'''[[Host, vector, one health, atmospheric aspects]]''' | | *'''[[Host, vector, one health, atmospheric aspects]]''' |
| − | {{tp|p=32300261|t=2020. Severe air pollution events not avoided by reduced anthropogenic activities during COVID-19 outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32333993|t=ä. Does the pathogenesis of SAR-CoV-2 virus decrease at high-altitude?|pdf=|usr=}}
| |
| − | {{tp|p=32304942|t=2020. Impact of meteorological factors on the COVID-19 transmission: A multi-city study in China |pdf=|usr=}}
| |
| − | {{tp|p=32375105|t=2020. Effect of lockdown amid COVID-19 pandemic on air quality of the megacity Delhi, India |pdf=|usr=}}
| |
| − | {{tp|p=32361460|t=2020. Effects of temperature and humidity on the daily new cases and new deaths of COVID-19 in 166 countries |pdf=|usr=}}
| |
| − | {{tp|p=32361428|t=2020. The impact of COVID-19 partial lockdown on the air quality of the city of Rio de Janeiro, Brazil |pdf=|usr=}}
| |
| − | {{tp|p=32361458|t=2020. Sunlight exposure increased Covid-19 recovery rates: A study in the central pandemic area of Indonesia |pdf=|usr=}}
| |
| − | {{tp|p=32353724|t=2020. Association between climate variables and global transmission oF SARS-CoV-2 |pdf=|usr=}}
| |
| − | {{tp|p=32361443|t=2020. Temperature significantly changes COVID-19 transmission in (sub)tropical cities of Brazil |pdf=|usr=}}
| |
| − | {{tp|p=32353722|t=2020. Air quality status during 2020 Malaysia Movement Control Order (MCO) due to 2019 novel coronavirus (2019-nCoV) pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32339844|t=ä. Impact of temperature on the dynamics of the COVID-19 outbreak in China |pdf=|usr=}}
| |
| − | {{tp|p=32361118|t=2020. A spatio-temporal analysis for exploring the effect of temperature on COVID-19 early evolution in Spain |pdf=|usr=}}
| |
| − | {{tp|p=32348946|t=2020. A preliminary assessment of the impact of COVID-19 on environment ? A case study of China |pdf=|usr=}}
| |
| − | {{tp|p=32335409|t=2020. Effect of restricted emissions during COVID-19 on air quality in India |pdf=|usr=}}
| |
| − | {{tp|p=32335408|t=2020. Environmental perspective of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32335407|t=2020. The sensitivity and specificity analyses of ambient temperature and population size on the transmission rate of the novel coronavirus (COVID-19) in different provinces of Iran |pdf=|usr=}}
| |
| − | {{tp|p=32334160|t=2020. Effect of weather on COVID-19 spread in the US: A prediction model for India in 2020 |pdf=|usr=}}
| |
| − | {{tp|p=32334164|t=ä. COVID-19 pandemic and environmental pollution: A blessing in disguise?|pdf=|usr=}}
| |
| − | {{tp|p=32334159|t=ä. Indirect effects of COVID-19 on the environment |pdf=|usr=}}
| |
| − | {{tp|p=32334158|t=ä. Impact of weather on COVID-19 pandemic in Turkey |pdf=|usr=}}
| |
| − | {{tp|p=32334162|t=2020. Correlation between climate indicators and COVID-19 pandemic in New York, USA |pdf=|usr=}}
| |
| − | {{tp|p=32335405|t=2020. COVID-19 transmission in Mainland China is associated with temperature and humidity: A time-series analysis |pdf=|usr=}}
| |
| − | {{tp|p=32361432|t=ä. Investigation of effective climatology parameters on COVID-19 outbreak in Iran |pdf=|usr=}}
| |
| − | {{tp|p=32315907|t=2020. What do we know about the SARS-CoV-2 coronavirus in the environment?|pdf=|usr=}}
| |
| − | {{tp|p=32315904|t=ä. Association between short-term exposure to air pollution and COVID-19 infection: Evidence from China |pdf=|usr=}}
| |
| − | {{tp|p=32302812|t=2020. Assessing nitrogen dioxide (NO2) levels as a contributing factor to coronavirus (COVID-19) fatality |pdf=|usr=}}
| |
| − | {{tp|p=32302810|t=ä. Changes in air quality during the lockdown in Barcelona (Spain) one month into the SARS-CoV-2 epidemic |pdf=|usr=}}
| |
| − | {{tp|p=32269068|t=2020. Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS?coronavirus 2 |pdf=|usr=}}
| |
| − | {{tp|p=32296757|t=ä. Air Pollution and the Novel Covid-19 Disease: a Putative Disease Risk Factor |pdf=|usr=}}
| |
| − | {{tp|p=32176808|t=2020. Potential impact of seasonal forcing on a SARS-CoV-2 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32112857|t=ä. COVID-19: Zoonotic aspects |pdf=|usr=}}
| |
| − | {{tp|p=32315124|t=2020. Is COVID-19 the first pandemic that evolves into a panzootic?|pdf=|usr=}}
| |
| − | {{tp|p=32048818|t=2020. Novel coronavirus (SARS-CoV-2) epidemic: a veterinary perspective |pdf=|usr=}}
| |
| − | {{tp|p=32361598|t=2020. Coronavirus in water environments: Occurrence, persistence and concentration methods - A scoping review |pdf=|usr=}}
| |
| − | {{ttp|p=32222047|t=2020. Coronavirus disease 2019 (COVID?19) outbreak: Could pigs be vectors for human infections?|pdf=|usr=}}
| |
| − | {{tp|p=32337151|t=ä. On the global trends and spread of the COVID-19 outbreak: preliminary assessment of the potential relation between location-specific temperature and UV index |pdf=|usr=}}
| |
| − | {{tp|p=32314559|t=2020. Zoonotic origins of human coronavirus 2019 (HCoV-19 / SARS-CoV-2): why is this work important?|pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Origin of Covid19]]''' | | *'''[[Origin of Covid19]]''' |
| − | {{tp|p=32155431|t=2020. Unveiling the Origin and Transmission of 2019-nCoV |pdf=|usr=}}
| |
| − | {{tp|p=32036774|t=2020. Emerging novel coronavirus (2019-nCoV)?current scenario, evolutionary perspective based on genome analysis and recent developments |pdf=|usr=}}
| |
| | | | |
| | | | |
| | *'''[[Epidemiology]]''' | | *'''[[Epidemiology]]''' |
| − | {{tp|p=32267109|t=2020. Coronavirus et COVID-19 : le point sur une pandemie galopante |pdf=|usr=}}
| |
| − | {{tp|p=32294667|t=ä. Translating transmissibility measures into recommendations for coronavirus prevention |pdf=|usr=}}
| |
| − | {{tp|p=32236385|t=ä. Outbreak investigation in cargo ship in times of COVID-19 crisis, Port of Santos, Brazil |pdf=|usr=}}
| |
| − | {{tp|p=32320998|t=ä. COVID-19 in Brazil: advantages of a socialized unified health system and preparation to contain cases |pdf=|usr=}}
| |
| − | {{tp|p=32215461|t=ä. The value of mitigating epidemic peaks of COVID-19 for more effective public health responses |pdf=|usr=}}
| |
| − | {{ttp|p=32296266|t=ä. Initial impacts of global risk mitigation measures taken during the combatting of the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32373394|t=ä. Using the contact network model and Metropolis-Hastings sampling to reconstruct the COVID-19 spread on the ?Diamond Princess? |pdf=|usr=}}
| |
| − | {{tp|p=32292631|t=ä. The inflection point about COVID-19 may have passed |pdf=|usr=}}
| |
| − | {{tp|p=32288968|t=2020. A data driven time-dependent transmission rate for tracking an epidemic: a case study of 2019-nCoV |pdf=|usr=}}
| |
| − | {{tp|p=32296594|t=ä. A systematic approach is needed to contain COVID-19 globally |pdf=|usr=}}
| |
| − | {{tp|p=32210236|t=2020. Epidemiological data from the COVID-19 outbreak, real-time case information |pdf=|usr=}}
| |
| − | {{tp|p=32334207|t=2020. Real-time estimation and prediction of mortality caused by COVID-19 with patient information based algorithm |pdf=|usr=}}
| |
| − | {{tp|p=32304973|t=2020. Evaluation of the lockdowns for the SARS-CoV-2 epidemic in Italy and Spain after one month follow up |pdf=|usr=}}
| |
| − | {{tp|p=32283308|t=2020. A field indoor air measurement of SARS-CoV-2 in the patient rooms of the largest hospital in Iran |pdf=|usr=}}
| |
| − | {{tp|p=32361455|t=2020. Modelling spatial variations of coronavirus disease (COVID-19) in Africa |pdf=|usr=}}
| |
| − | {{tp|p=32375067|t=ä. Prediction of the COVID-19 spread in African countries and implications for prevention and controls: A case study in South Africa, Egypt, Algeria, Nigeria, Senegal and Kenya |pdf=|usr=}}
| |
| − | {{tp|p=32361446|t=2020. SutteARIMA: Short-term forecasting method, a case: Covid-19 and stock market in Spain |pdf=|usr=}}
| |
| − | {{tp|p=32371231|t=2020. Computational analysis of SARS-CoV-2/COVID-19 surveillance by wastewater-based epidemiology locally and globally: Feasibility, economy, opportunities and challenges |pdf=|usr=}}
| |
| − | {{tp|p=32336562|t=ä. Restructured society and environment: A review on potential technological strategies to control the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32339832|t=2020. Inter nation social lockdown versus medical care against COVID-19, a mild environmental insight with special reference to India |pdf=|usr=}}
| |
| − | {{tp|p=32334157|t=ä. Prediction for the spread of COVID-19 in India and effectiveness of preventive measures |pdf=|usr=}}
| |
| − | {{tp|p=32334161|t=2020. Can we predict the occurrence of COVID-19 cases? Considerations using a simple model of growth |pdf=|usr=}}
| |
| − | {{tp|p=32330703|t=2020. Effectiveness of the measures to flatten the epidemic curve of COVID-19 The case of Spain |pdf=|usr=}}
| |
| − | {{tp|p=32371477|t=ä. Rapid implementation of mobile technology for real-time epidemiology of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32234804|t=2020. An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China |pdf=|usr=}}
| |
| − | {{tp|p=32234805|t=2020. Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing |pdf=|usr=}}
| |
| − | {{tp|p=32213647|t=ä. The effect of human mobility and control measures on the COVID-19 epidemic in China |pdf=|usr=}}
| |
| − | {{tp|p=32179701|t=ä. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2) |pdf=|usr=}}
| |
| − | {{tp|p=32144116|t=2020. The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32350060|t=ä. Changes in contact patterns shape the dynamics of the COVID-19 outbreak in China |pdf=|usr=}}
| |
| − | {{tp|p=32269067|t=2020. Effective containment explains subexponential growth in recent confirmed COVID-19 cases in China |pdf=|usr=}}
| |
| − | {{tp|p=32291278|t=ä. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period |pdf=|usr=}}
| |
| − | {{tp|p=32211911|t=2020. A midpoint perspective on the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=C7139267|t=ä. Determining the spatial effects of COVID-19 using the spatial panel data model |pdf=|usr=}}
| |
| − | {{tp|p=32292884|t=ä. Important Steps to Control COVID-19/SARS-CoV-2 Infection |pdf=|usr=}}
| |
| − | {{tp|p=C7113380|t=ä. On a Statistical Transmission Model in Analysis of the Early Phase of COVID-19 Outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32191813|t=2020. COVID-19 epidemic in Switzerland: on the importance of testing, contact tracing and isolation |pdf=|usr=}}
| |
| − | {{tp|p=32365217|t=2020. Reproductive number of the COVID-19 epidemic in Switzerland with a focus on the Cantons of Basel-Stadt and Basel-Landschaft |pdf=|usr=}}
| |
| − | {{tp|p=32031234|t=2020. 2019-novel Coronavirus (2019-nCoV): estimating the case fatality rate - a word of caution |pdf=|usr=}}
| |
| − | {{tp|p=32227799|t=2020. Preliminary case report on the SARS-CoV-2 cluster in the UK, France, and Spain|pdf=|usr=}}
| |
| − | {{tp|p=32333603|t=2020. Transmission risk of SARS-CoV-2 to healthcare workers -observational results of a primary care hospital contact tracing |pdf=|usr=}}
| |
| − | {{tp|p=32343357|t=2020. The global COVID-19 response must include refugees and migrants |pdf=|usr=}}
| |
| − | {{tp|p=32222421|t=ä. Importing coronavirus disease 2019 (COVID-19) into China after international air travel? |pdf=|usr=}}
| |
| − | {{tp|p=32205270|t=ä. Should the Holy Week 2020 be cancelled in Latin America due to the COVID-19 pandemic?|pdf=|usr=}}
| |
| − | {{tp|p=32184130|t=ä. Mapping the incidence of the COVID-19 hotspot in Iran ? Implications for Travellers |pdf=|usr=}}
| |
| − | {{tp|p=32184132|t=ä. Spatial transmission of COVID-19 via public and private transportation in China |pdf=|usr=}}
| |
| − | {{tp|p=32184128|t=ä. Is Romania ready to face the novel coronavirus (COVID-19) outbreak? The role of incoming travelers and that of Romanian diaspora |pdf=|usr=}}
| |
| − | {{tp|p=32179125|t=ä. Testing the repatriated for SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine?|pdf=|usr=}}
| |
| − | {{tp|p=32165283|t=ä. COVID-19 ? the role of mass gatherings |pdf=|usr=}}
| |
| − | {{tp|p=32032674|t=ä. Outbreak of novel Corona virus (2019-nCoV); implications for travelers to Pakistan |pdf=|usr=}}
| |
| − | {{tp|p=32006656|t=2020. The association between domestic train transportation and novel coronavirus (2019-nCoV) outbreak in China from 2019 to 2020: A data-driven correlational report |pdf=|usr=}}
| |
| − | {{tp|p=32278757|t=ä. COVID-19: Travel health and the implications for sub -Saharan Africa |pdf=|usr=}}
| |
| − | {{tp|p=32278756|t=ä. COVID-19 and dengue fever: A dangerous combination for the health system in Brazil |pdf=|usr=}}
| |
| − | {{tp|p=32268196|t=ä. COVID-19 and dengue, co-epidemics in Ecuador and other countries in Latin America: Pushing strained health care systems over the edge |pdf=|usr=}}
| |
| − | {{tp|p=32360422|t=2020. Primum non nocere: Potential indirect adverse effects of COVID-19 containment strategies in the African region |pdf=|usr=}}
| |
| − | {{tp|p=32360326|t=2020. Prevalence and fatality rates of COVID-19: What are the reasons for the wide variations worldwide?|pdf=|usr=}}
| |
| − | {{tp|p=32353629|t=ä. More data are required for incubation period, infectivity, and quarantine duration for COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32344113|t=ä. The effect of uncontrolled travelers and social distancing on the spread of novel coronavirus disease (COVID-19) in Colombia |pdf=|usr=}}
| |
| − | {{tp|p=32334090|t=ä. The vulnerability of low-and middle-income countries facing the COVID-19 pandemic: The case of Haiti |pdf=|usr=}}
| |
| − | {{tp|p=32334086|t=ä. Travel rush during Chinese Spring Festival and the 2019-nCoV |pdf=|usr=}}
| |
| − | {{tp|p=32334084|t=ä. Incidence of coronavirus disease (COVID-19) and countries affected by malarial infections |pdf=|usr=}}
| |
| − | {{tp|p=32330561|t=ä. COVID-19 social distancing in the Kingdom of Saudi Arabia: Bold measures in the face of political, economic, social and religious challenges |pdf=|usr=}}
| |
| − | {{tp|p=32330560|t=ä. Presumptive asymptomatic COVID-19 carriers? estimation and expected person-to-person spreading among repatriated passengers returning from China |pdf=|usr=}}
| |
| − | {{tp|p=32325120|t=ä. The reproductive number R0 of COVID-19 in Peru: An opportunity for effective changes |pdf=|usr=}}
| |
| − | {{tp|p=32247931|t=2020. Incidence of novel coronavirus (2019-nCoV) infection among people under home quarantine in Shenzhen, China |pdf=|usr=}}
| |
| − | {{tp|p=32315756|t=ä. Challenges of managing the asymptomatic carriers of SARS-CoV-2 |pdf=|usr=}}
| |
| − | {{tp|p=32304743|t=ä. Modelling the epidemic spread of COVID-19 virus infection in Northern African countries |pdf=|usr=}}
| |
| − | {{tp|p=32289549|t=ä. What are the factors influencing the COVID-19 outbreak in Latin America?|pdf=|usr=}}
| |
| − | {{tp|p=32247928|t=ä. Summary of the COVID-19 outbreak in Vietnam ? Lessons and suggestions |pdf=|usr=}}
| |
| − | {{tp|p=32247016|t=ä. Probable aircraft transmission of Covid-19 in-flight from the Central African Republic to France |pdf=|usr=}}
| |
| − | {{tp|p=32304192|t=2020. COVID-19 outbreak control, example of ministry of health of Turkey |pdf=|usr=}}
| |
| − | {{tp|p=32288543|t=2020. Is Sub-Saharan Africa prepared for COVID-19?|pdf=|usr=}}
| |
| − | {{tp|p=32299206|t=2020. Epidemiology of COVID-19|pdf=|usr=}}
| |
| − | {{tp|p=32299204|t=2020. Understanding dynamics of pandemics |pdf=|usr=}}
| |
| − | {{tp|p=32293835|t=2020. COVID-19: Prevention and control measures in community |pdf=|usr=}}
| |
| − | {{tp|p=32283894|t=2020. SARS-CoV-2 epidemiology and control, different scenarios for Turkey|pdf=|usr=}}
| |
| − | {{tp|p=32239446|t=ä. The Rapid Assessment and Early Warning Models for COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32313825|t=ä. Coronavirus threat to Indian population: risk factors, transmission dynamics and preparedness to prevent the spread of the virus |pdf=|usr=}}
| |
| − | {{tp|p=32322691|t=2020. The transmissibility of novel Coronavirus in the early stages of the 2019-20 outbreak in Wuhan: Exploring initial point-source exposure sizes and durations using scenario analysis |pdf=|usr=}}
| |
| − | {{tp|p=32341214|t=2020. Quo vadis after COVID-19: a new path for global emergency preparedness?|pdf=|usr=}}
| |
| − | {{tp|p=32368532|t=2020. Stability and infectivity of coronaviruses in inanimate environments |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| | | | |
| | | | |
| | *'''[[Remission, recurrence and persistence]]''' | | *'''[[Remission, recurrence and persistence]]''' |
| − | {{tp|p=32308203|t=2020. Patients with respiratory symptoms are at greater risk of COVID-19 transmission |pdf=|usr=}}
| |
| − | {{tp|p=32160971|t=ä. Positive result of Sars-Cov-2 in sputum from a cured patient with COVID-19 |pdf=|usr=}}
| |
| | | | |
| | *'''[[Failure of executive measures]]''' | | *'''[[Failure of executive measures]]''' |
| Zeile 660: |
Zeile 141: |
| | ---- | | ---- |
| | *'''[[Failure of politics and public health guidance]]''' | | *'''[[Failure of politics and public health guidance]]''' |
| − | {{tp|p=C7111621|t=ä. Science Education in the Era of a Pandemic: How Can History, Philosophy and Sociology of Science Contribute to Education for Understanding and Solving the Covid-19 Crisis?|pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Political abuse of Covid19]]''' | | *'''[[Political abuse of Covid19]]''' |
| − | {{tp|p=32203324|t=ä. COVID-19 and the crisis of national development |pdf=|usr=}}
| |
| − | {{tp|p=32205267|t=ä. YouTube as source of information on 2019 novel coronavirus outbreak: a cross sectional study of English and Mandarin content |pdf=|usr=}}
| |
| | | | |
| | | | |
| Zeile 675: |
Zeile 152: |
| | | | |
| | *'''[[History of covid19 exploration]]''' | | *'''[[History of covid19 exploration]]''' |
| − | {{tp|p=32088858|t=ä. Puzzle of highly pathogenic human coronaviruses (2019-nCoV) |pdf=|usr=}}
| |
| − | {{tp|p=32334163|t=2020. Overview of Covid-19; its prevention and management in the light of Unani medicine |pdf=|usr=}}
| |
| − | {{tp|p=32335410|t=2020. COVID-19 outbreak: Migration, effects on society, global environment and prevention |pdf=|usr=}}
| |
| − | {{ttp|p=32296735|t=ä. Prudently conduct the engineering and synthesis of the SARS-CoV-2 virus |pdf=|usr=}}
| |
| − | {{tp|p=32198918|t=2020. COVID-19: a fast evolving pandemic |pdf=|usr=}}
| |
| − | {{tp|p=C7138902|t=ä. Emergence of deadly severe acute respiratory syndrome coronavirus-2 during 2019?2020 |pdf=|usr=}}
| |
| − | {{tp|p=32313822|t=ä. Recent apprise on coronavirus and its terrible insinuations |pdf=|usr=}}
| |
| − | {{tp|p=32230900|t=2020. Virology, Epidemiology, Pathogenesis, and Control of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=31991541|t=2020. Return of the Coronavirus: 2019-nCoV |pdf=|usr=}}
| |
| − | {{tp|p=31979013|t=2020. Emerging Viruses without Borders: The Wuhan Coronavirus |pdf=|usr=}}
| |
| − |
| |
| | | | |
| − | *'''[[misc.]]''' | + | *'''[[misc.]]'''}} |
| − | {{tp|p=32361911|t=ä. Single-cell transcriptome analysis of the novel coronavirus (SARS-CoV-2) associated gene ACE2 expression in normal and non-obstructive azoospermia (NOA) human male testes |pdf=|usr=}}
| + | |
| − | {{tp|p=32313360|t=ä. AI governance in the public sector: Three tales from the frontiers of automated decision-making in democratic settings |pdf=|usr=}}
| + | |
| − | {{tp|p=32371196|t=ä. Theme: Information on the Covid-19 pandemic |pdf=|usr=}}
| + | |
| − | {{tp|p=32234457|t=ä. COVID-19 in children: More than meets the eye |pdf=|usr=}}
| + | |
| − | {{tp|p=32044387|t=2020. Maps, masks and media ? Traveller and practitioner resources for 2019 novel coronavirus (2019-nCoV) acute respiratory virus |pdf=|usr=}}
| + | |
| − | {{tp|p=32035269|t=2020. What goes on board aircraft? Passengers include Aedes, Anopheles, 2019-nCoV, dengue, Salmonella, Zika, et al |pdf=|usr=}}
| + | |
| − | {{tp|p=32299208|t=2020. Mobilizing the research ecosystem for scientific advances towards positive impact in the context of the COVID-19 Pandemic |pdf=|usr=}}
| + | |
| − | {{tp|p=32370128|t=2020. Dengue Fever and Severe Dengue in Barbados, 2008-2016 |pdf=|usr=}}
| + | |
| − | {{tp|p=32368550|t=2020. Pulmonary contusion mimicking COVID-19: A case report |pdf=|usr=}}
| + | |
| | | | |
| | *'''[[Research tools]]''' | | *'''[[Research tools]]''' |
| Zeile 702: |
Zeile 159: |
| | | | |
| | | | |
| − | *'''[[PrePrint scene''']] | + | *'''[[PrePrint scene]]''' |
| | *[https://prelights.biologists.com/ prelights] | | *[https://prelights.biologists.com/ prelights] |
| | | | |
